Management of diabetes in people with advanced chronic kidney disease

TA Chowdhury, D Mukuba, M Casabar… - Diabetic …, 2024 - Wiley Online Library
Diabetes is the commonest cause of end stage kidney disease globally, accounting for
almost 40% of new cases requiring renal replacement therapy. Management of diabetes in …

[HTML][HTML] The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin

EC Nijenhuis-Noort, KA Berk… - Endocrinology and …, 2024 - synapse.koreamed.org
This review intends to provide the reader with a practical overview of several (patho)
physiological conditions in which knowledge of the interplay between growth hormone (GH) …

Challenges in Management of Diabetic Patient on Dialysis

MT Eldehni, LE Crowley, NM Selby - Kidney and Dialysis, 2022 - mdpi.com
Diabetes mellitus is the leading cause of end-stage kidney disease in many countries. The
management of diabetic patients who receive dialysis can be challenging. Diabetic dialysis …

Complications of Peritoneal Dialysis Part II: Nonmechanical Complications

XBJ Cheng, J Bargman - Clinical Journal of the American Society …, 2024 - journals.lww.com
Peritoneal dialysis (PD) is a form of kidney replacement therapy that offers flexibility and
autonomy to patients with end stage kidney disease. It is associated with lower costs …

[HTML][HTML] Narrative review of glycemic management in people with diabetes on peritoneal dialysis

P Wijewickrama, J Williams, S Bain, I Dasgupta… - Kidney International …, 2023 - Elsevier
There is an increasing number of people with diabetes on peritoneal dialysis (PD)
worldwide. However, there is a lack of guidelines and clinical recommendations for …

Current status and influencing factors of kinesiophobia in patients with peritoneal dialysis: a multicenter cross-sectional study

M Xie, L Yin, Y Guo, X Zhang, R Zhao - BMC nephrology, 2024 - Springer
Background Kinesiophobia, an irrational fear-avoidance behaviour, can significantly impact
the quality of life and prognosis of peritoneal dialysis patients. This study aimed to assess …

Management of hyperglycemia in the noncritical care setting: A real-world case-based approach with alternative insulin-and noninsulin-based strategies

S Dowlatshahi, B Patham, J Shakil, M Zahid… - Diabetes …, 2022 - Am Diabetes Assoc
Insulin remains the mainstay of treatment for inpatient hyperglycemia in the United States
and Canada. However, some other countries commonly use noninsulin agents such as …

基于最佳证据的血液透析病人血糖管理指导流程图的构建.

卢红华, 肖丽萍, 刘燕燕 - Chinese Nursing Research, 2023 - search.ebscohost.com
摘要目的: 评价并总结血液透析病人血糖管理的相关证据, 根据最佳证据构建血液透析病人血糖
管理指导流程图, 为临床指导血液透析病人血糖管理提供依据. 方法: 系统检索中国知网, 万方 …

Treatment of Type 2 Diabetes Mellitus in Advanced Chronic Kidney Disease for the Primary Care Physician

M Mallappallil, S Sasidharan, J Sabu, S John - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Diabetes mellitus (DM) is a common cause of chronic kidney disease (CKD), leading to the
need for renal replacement therapy (RRT). RRT includes hemodialysis (HD), peritoneal …

[HTML][HTML] Phased therapeutic intervention improves long-term prognosis of new hemodialysis patients

J Sun, F Guo, D Wan, Y Wang - Pakistan Journal of Medical …, 2024 - pmc.ncbi.nlm.nih.gov
Objective: To explore the effect of phased therapeutic intervention in improving the long-term
prognosis of new hemodialysis (HD) patients. Method: This was a retrospective study. A total …